Stay updated on Phase II Pembrolizumab Plus GVD Clinical Trial

Sign up to get notified when there's something new on the Phase II Pembrolizumab Plus GVD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase II Pembrolizumab Plus GVD Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    New update dates (2026-06-17, 2026-06-16, 2026-06) were added and older dates (2026-04-16, 2026-04-13, 2026-04) were removed from the update history, signaling recent activity on the study page.
    Difference
    0.2%
    Check dated 2026-06-20T05:31:23.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    New helper links were added to the study page (Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, How to Join a Study) and the page’s revision tag was updated to v3.6.0; the Intervention heading was reformatted from 'Intervention / Treatment' to 'Intervention/Treatment'.
    Difference
    0.4%
    Check dated 2026-06-13T01:28:17.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page's revision label has been updated to v3.5.5, indicating a recent deployment of site updates.
    Difference
    0.0%
    Check dated 2026-06-05T22:10:31.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    The study record page shows a revision label updated from v3.5.3 to v3.5.4, indicating a small update to the page’s metadata. This change does not alter the study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-05-15T09:09:12.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    New bibliographic entries were added to the Publications section, including a 2026 article on checkpoint inhibitors in Hodgkin lymphoma, and a note that PubMed entries may be auto-filled from PubMed.
    Difference
    0.1%
    Check dated 2026-05-08T09:30:07.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    A minor update to the ClinicalTrials.gov page’s displayed software/version revision number (from v3.5.2 to v3.5.3) occurred, without any visible change to the trial’s study details.
    Difference
    0.0%
    Check dated 2026-04-24T05:45:09.000Z thumbnail image

Stay in the know with updates to Phase II Pembrolizumab Plus GVD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase II Pembrolizumab Plus GVD Clinical Trial page.